Skip to main content

Dr. Usha S. Perepu, MBBS

Hematology & Oncology (Hematology & Oncology Physician)

  • Medicare participating

At a glance

Years since graduation
28
In the NPI registry since
2010
Medicare patients seen, 2024
77

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is

Education and training

  • 2010Registered with an NPI (national billing number; not a license date)

Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Hematology & Oncology Physician primary
    IA license 41239
  • Internal Medicine Physician
    IA license 41239

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Hematology & Oncology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
77
Services billed
164
Patients’ average age
69
Most frequent Medicare services, 2023
ServiceTimesPatients
Established patient office or other outpatient visit, 20-29 minutes8568
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes3115
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes2018
Established patient office or other outpatient visit, 30-39 minutes2018
New patient office or other outpatient visit, 45-59 minutes1818
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes1111

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Most prescribed drugs, Medicare Part D 2024
DrugPrescriptions
Fondaparinux Sodium12

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 3 companies reported 42 payments worth $47,678 in total to this clinician.

By company
Genzyme Corporation$30,416
Agios Pharmaceuticals, Inc.$17,239
Blueprint Medicines Corporation$22.40
By type
Consulting Fee$24,650
Compensation for services other than consulting (speaking, faculty)$16,718
Travel and Lodging$4,757
Food and Beverage$1,553

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
May 16, 2025Genzyme Corporation
May 16, 2025
Consulting Fee
QFITLIA
$9,030
Aug 15, 2025Genzyme Corporation
Aug 15, 2025
Consulting Fee
ALTUVIIIO · Hematology
$7,525
Jun 10, 2025Agios Pharmaceuticals, Inc.
Jun 10, 2025
Consulting Fee
PYRUKYND · Genetically Defined Disease
$6,660
Sep 25, 2025Genzyme Corporation
Sep 25, 2025
Compensation for services other than consulting (speaking, faculty)
ALTUVIIIO · Hematology
$4,888
Oct 17, 2025Agios Pharmaceuticals, Inc.
Oct 17, 2025
Compensation for services other than consulting (speaking, faculty)
PYRUKYND · Genetically Defined Disease
$4,715
Apr 9, 2025Genzyme Corporation
Apr 9, 2025
Compensation for services other than consulting (speaking, faculty)
ALTUVIIIO · Hematology
$2,300
Dec 11, 2025Agios Pharmaceuticals, Inc.
Dec 11, 2025
Compensation for services other than consulting (speaking, faculty)
PYRUKYND · Genetically Defined Disease
$1,940
Sep 18, 2025Genzyme Corporation
Sep 18, 2025
Compensation for services other than consulting (speaking, faculty)
QFITLIA · Hematology
$1,150
Mar 20, 2025Genzyme Corporation
Mar 20, 2025
Compensation for services other than consulting (speaking, faculty)
ALTUVIIIO · Hematology
$1,150
Jul 3, 2025Agios Pharmaceuticals, Inc.
Jul 3, 2025
Consulting Fee
PYRUKYND · Genetically Defined Disease
$833
All 28 payments other than meals, newest first
All payments other than meals
DateCompanyWhat it was forAmount
Dec 11, 2025Agios Pharmaceuticals, Inc.
Dec 11, 2025
Compensation for services other than consulting (speaking, faculty)
PYRUKYND · Genetically Defined Disease
$1,940
Dec 11, 2025Agios Pharmaceuticals, Inc.
Dec 11, 2025
Travel and Lodging
PYRUKYND · Genetically Defined Disease · travel to Houston, TX, TX
$539
Oct 17, 2025Agios Pharmaceuticals, Inc.
Oct 17, 2025
Compensation for services other than consulting (speaking, faculty)
PYRUKYND · Genetically Defined Disease
$4,715
Oct 17, 2025Agios Pharmaceuticals, Inc.
Oct 17, 2025
Travel and Lodging
PYRUKYND · Genetically Defined Disease · travel to Bellevue, WA
$551
Oct 17, 2025Agios Pharmaceuticals, Inc.
Oct 17, 2025
Travel and Lodging
PYRUKYND · Genetically Defined Disease · travel to Bellevue, WA
$233
Oct 17, 2025Agios Pharmaceuticals, Inc.
Oct 17, 2025
Travel and Lodging
PYRUKYND · Genetically Defined Disease · travel to Bellevue, WA
$214
Sep 25, 2025Genzyme Corporation
Sep 25, 2025
Compensation for services other than consulting (speaking, faculty)
ALTUVIIIO · Hematology
$4,888
Sep 25, 2025Genzyme Corporation
Sep 25, 2025
Travel and Lodging
ALTUVIIIO · Hematology · travel to Austin, TX
$112
Sep 25, 2025Genzyme Corporation
Sep 25, 2025
Travel and Lodging
ALTUVIIIO · Hematology · travel to Austin, TX
$33.34
Sep 18, 2025Genzyme Corporation
Sep 18, 2025
Compensation for services other than consulting (speaking, faculty)
QFITLIA · Hematology
$1,150
Aug 15, 2025Genzyme Corporation
Aug 15, 2025
Consulting Fee
ALTUVIIIO · Hematology
$7,525
Aug 15, 2025Genzyme Corporation
Aug 15, 2025
Compensation for services other than consulting (speaking, faculty)
ALTUVIIIO · Hematology
$575
Aug 15, 2025Genzyme Corporation
Aug 15, 2025
Travel and Lodging
ALTUVIIIO · Hematology · travel to New Orleans, LA · in-kind
$383
Aug 15, 2025Genzyme Corporation
Aug 15, 2025
Travel and Lodging
ALTUVIIIO · Hematology · travel to New Orleans, LA · in-kind
$381
Aug 15, 2025Genzyme Corporation
Aug 15, 2025
Travel and Lodging
ALTUVIIIO · Hematology · travel to New Orleans, LA · in-kind
$153
Aug 15, 2025Genzyme Corporation
Aug 15, 2025
Travel and Lodging
ALTUVIIIO · Hematology · travel to New Orleans, LA
$88.31
Jul 3, 2025Agios Pharmaceuticals, Inc.
Jul 3, 2025
Consulting Fee
PYRUKYND · Genetically Defined Disease
$833
Jun 18, 2025Agios Pharmaceuticals, Inc.
Jun 18, 2025
Travel and Lodging
PYRUKYND · Genetically Defined Disease · travel to Los Angeles, CA
$144
Jun 10, 2025Agios Pharmaceuticals, Inc.
Jun 10, 2025
Consulting Fee
PYRUKYND · Genetically Defined Disease
$6,660
May 29, 2025Genzyme Corporation
May 29, 2025
Consulting Fee$602
May 17, 2025Agios Pharmaceuticals, Inc.
May 17, 2025
Travel and Lodging
PYRUKYND · Genetically Defined Disease · travel to Los Angeles, CA
$814
May 17, 2025Agios Pharmaceuticals, Inc.
May 17, 2025
Travel and Lodging
PYRUKYND · Genetically Defined Disease · travel to Los Angeles, CA
$227
May 16, 2025Genzyme Corporation
May 16, 2025
Consulting Fee
QFITLIA
$9,030
May 16, 2025Genzyme Corporation
May 16, 2025
Travel and Lodging
QFITLIA · travel to Cambridge, MA · in-kind
$537
May 16, 2025Genzyme Corporation
May 16, 2025
Travel and Lodging
QFITLIA · travel to Cambridge, MA · in-kind
$313
May 16, 2025Genzyme Corporation
May 16, 2025
Travel and Lodging
QFITLIA · travel to Cambridge, MA
$33.29
Apr 9, 2025Genzyme Corporation
Apr 9, 2025
Compensation for services other than consulting (speaking, faculty)
ALTUVIIIO · Hematology
$2,300
Mar 20, 2025Genzyme Corporation
Mar 20, 2025
Compensation for services other than consulting (speaking, faculty)
ALTUVIIIO · Hematology
$1,150

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Iowa →

Industry-funded research

Named as a principal investigator on 3 industry-funded studies in 2025, from 3 companies. The companies reported $49,563 in research payments for these studies, mostly to the institutions running them.

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Hematology & Oncology clinicians in Iowa City

Sources

NPI registry (CMS NPPES, November 2026; record last updated August 2, 2013), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1497060776. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.